AHA Coding Clinic® for HCPCS - 2014 Quarter 4; For Your Information
New HCPCS codes for certain drugs, biologicals and radiopharmaceuticals
Several new HCPCS codes were created for the reporting of drugs and biologicals and became effective for calendar year (CY) 2015 in the hospital outpatient setting. These new HCPCS codes are listed in the table below: CY 2015 HCPCS code CY 2015 Long Descriptor A9606 Radium ra-223 dichloride, therapeutic, per microcurie C9027 Injection, pembrolizumab, 1 mg C9136 Injection, factor viii, fe fusion protein, (recombinant), per i.u. C9349 FortaDerm, and FortaDerm Antimicrobial, any type, per square centimeter C9442 Injection, belinostat, 10 mg C9443 Injection, dalbavancin, 10 mg C9444 Injection, oritavancin, 10 mg C9446 Injection, tedizolid phosphate, 1 mg C9447...
Subscribe or sign in to view the full article.
Article Overview
This article summarizes a set of newly created HCPCS reporting codes that became effective for calendar year 2015 in the hospital outpatient setting. It is relevant for hospital outpatient coders, billing staff, and revenue cycle professionals who need to track HCPCS updates for drugs, biologics, radiopharmaceuticals, and related products. The article presents the code updates in a table format and is useful for identifying the scope of the 2015 additions.
Why This Topic Matters
Keeping current with HCPCS updates helps outpatient facilities maintain accurate reporting for drugs, biologicals, and related items. Articles like this support code-set awareness and annual update review workflows.
What You Will Learn
- Which broad categories of HCPCS updates were introduced for the 2015 hospital outpatient setting.
- How the article organizes newly effective reporting codes for drugs, biologicals, and radiopharmaceuticals.
- Which types of products were included among the 2015 HCPCS additions.
- intended_audiences":["Hospital outpatient coders","Billing staff","Revenue cycle professionals","Outpatient reimbursement specialists"],
- topics":["HCPCS updates","calendar year 2015","hospital outpatient setting","drugs","biologicals","radiopharmaceuticals"],
- medical_specialties":["Hospital outpatient","Oncology","Pharmacy","Radiology"],
- code_sets":["HCPCS Level II"],
- codes":[{"code_set":"HCPCS Level II","code":"A9606"},{"code_set":"HCPCS Level II","code":"C9027"},{"code_set":"HCPCS Level II","code":"C9136"},{"code_set":"HCPCS Level II","code":"C9349"},{"code_set":"HCPCS Level II","code":"C9442"},{"code_set":"HCPCS Level II","code":"C9443"},{"code_set":"HCPCS Level II","code":"C9444"},{"code_set":"HCPCS Level II","code":"C9446"},{"code_set":"HCPCS Level II","code":"C9447"},{"code_set":"HCPCS Level II","code":"J0571"},{"code_set":"HCPCS Level II","code":"J0572"},{"code_set":"HCPCS Level II","code":"J0573"},{"code_set":"HCPCS Level II","code":"J0574"},{"code_set":"HCPCS Level II","code":"J0575"},{"code_set":"HCPCS Level II","code":"J1826"},{"code_set":"HCPCS Level II","code":"J2704"},{"code_set":"HCPCS Level II","code":"J7182"},{"code_set":"HCPCS Level II","code":"J7301"},{"code_set":"HCPCS Level II","code":"J7302"},{"code_set":"HCPCS Level II","code":"J7327"},{"code_set":"HCPCS Level II","code":"J8565"},{"code_set":"HCPCS Level II","code":"Q4150"},{"code_set":"HCPCS Level II","code":"Q4151"},{"code_set":"HCPCS Level II","code":"Q4152"},{"code_set":"HCPCS Level II","code":"Q4153"},{"code_set":"HCPCS Level II","code":"Q4154"},{"code_set":"HCPCS Level II","code":"Q4155"},{"code_set":"HCPCS Level II","code":"Q4156"},{"code_set":"HCPCS Level II","code":"Q4157"},{"code_set":"HCPCS Level II","code":"Q4158"},{"code_set":"HCPCS Level II","code":"Q4159"},{"code_set":"HCPCS Level II","code":"Q4160"}],
Who Should Read This
- Hospital outpatient coders
- Billing staff
- Revenue cycle professionals
- Outpatient reimbursement specialists
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com